Ahram Online joined experts in Cairo on 5 December for the ninth International Association for Chest and Lung Tumours (ONTIC) ...

A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with ...

A study identified two key genes (CTNNA1 and BCL2L13) as suppressors in spread of colorectal cancer, revealing new strategies ...

The problem, Zaaijer explained, is that algorithms used in precision medicine models overwhelming are built on DNA with ...

A new study found that Black women face up to 70 per cent higher death rates from breast cancer compared to white women, ...

The first 100 bases of many genes show excess mutations, revealing a major genomic weak spot that shapes disease risk and ...

Have you ever bitten into a supermarket tomato and wondered where all the flavor went? You're not imagining things. That ...

What are organoids and how are they developed? How can they be used to help people and what are the advantages of using them?

ORLANDO, Dec. 7, 2025) A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with ...

Invicta Diagnostic is set to debut on the NSE SME platform on December 8, following a successful IPO that raised 28.12 crore.

(51 of 54) remained free from the burden of continuous prophylaxis treatment through five years following a single infusion of HEMGENIX, demonstrating sustained therapeutic benefit- At year five, mean ...